Docoh
Loading...

DRRX Durect

News

From Benzinga Pro
Data Says Presentation Today At The Liver Meeting 2021 Shows Increasing Hospital Admissions For Alcohol-Associated Hepatitis (AH) In The U.S.
12 Nov 21
News, FDA, Events
DURECT Corporation (NASDAQ:DRRX) today announced the presentation of data at the American Association for The Study of Liver Diseases (AASLD) The Liver Meeting® 2021 showcasing an increase of
Durect Q3 EPS $(0.04) Beats $(0.05) Estimate, Sales $2.17M Beat $1.95M Estimate
2 Nov 21
Earnings, News
Durect (NASDAQ:DRRX) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.05) by 20 percent. This is a 20 percent increase over losses of $(0.05) per share from the same period
Earnings Scheduled For November 2, 2021
2 Nov 21
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • Thomson Reuters (NYSE:TRI) is expected to report quarterly earnings at $0.48 per share on revenue of $1.86 billion.
12 Health Care Stocks Moving In Friday's Intraday Session
29 Oct 21
Intraday Update, Markets, Movers
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
7 Oct 21
Biotech, News, Penny Stocks, Offerings, Small Cap, FDA
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6)
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
6 Oct 21
Biotech, News, Penny Stocks, Small Cap, FDA
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5)

Press releases

From Benzinga Pro
DURECT Corporation to Participate in Alcoholic Liver Disease Workshop Today at the 5th Annual NASH Summit
29 Nov 21
Press Releases
CUPERTINO, Calif., Nov. 29, 2021 /PRNewswire/ -- DURECT Corporation (NASDAQ:DRRX) announced it will participate in a workshop today at the 5th Annual NASH Summit being held virtually from today through December 2, 2021.
Data Presentation Today at The Liver Meeting® 2021 Shows Increasing Hospital Admissions for Alcohol-Associated Hepatitis (AH) in the U.S.
12 Nov 21
Press Releases
CUPERTINO, Calif., Nov. 12, 2021 /PRNewswire/ -- DURECT Corporation (NASDAQ:DRRX) today announced the presentation of data at the American Association for The Study of Liver Diseases (AASLD) The Liver Meeting® 2021
DURECT Corporation Reports Third Quarter 2021 Financial Results and Update of Programs
2 Nov 21
Earnings, Press Releases
CUPERTINO, Calif., Nov. 2, 2021 /PRNewswire/ -- DURECT Corporation (NASDAQ:DRRX) today announced financial results for the three months ended September 30, 2021 and provided a corporate update. "I am proud of the
DURECT Corporation to Announce Third Quarter 2021 Financial Results and Provide Business Update on November 2
26 Oct 21
Press Releases
CUPERTINO, Calif., Oct. 26, 2021 /PRNewswire/ -- DURECT Corporation (NASDAQ:DRRX) today announced that it will report its third quarter 2021 financial results and host a conference call after the market close on Tuesday,
DURECT Corporation Fireside Chat at the H.C. Wainwright 5th Annual NASH Investor Conference
7 Oct 21
Press Releases
CUPERTINO, Calif., Oct. 7, 2021 /PRNewswire/ -- DURECT Corporation (NASDAQ:DRRX) today announced that Dr. James E. Brown, President and CEO, Michael H. Arenberg, Chief Financial Officer, Dr. Norman Sussman, Chief Medical
DURECT Corporation Fireside Chat at the Cantor Fitzgerald Global Healthcare Conference 2021
23 Sep 21
Press Releases
CUPERTINO, Calif., Sept. 23, 2021 /PRNewswire/ -- DURECT Corporation (NASDAQ:DRRX) today announced that Dr. James E. Brown, President and CEO, Michael H. Arenberg, Chief Financial Officer, Dr. Norman Sussman, Chief
DURECT Corporation Fireside Chat at Oppenheimer's Fall Healthcare Life Sciences & MedTech Summit
15 Sep 21
Press Releases
CUPERTINO, Calif., Sept. 15, 2021 /PRNewswire/ -- DURECT Corporation (NASDAQ:DRRX) today announced that Dr. James E. Brown, President and CEO, Michael H. Arenberg, Chief Financial Officer, Dr. Norman Sussman, Chief